T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PKST
2601
Peakstone Realty Trust
PKST
$519M
| $205K | ﹤0.01% |
16,249
+1,658
| +11% | +$20.9K |
|
2602
American Axle
AXL
$697M
| $204K | ﹤0.01% |
49,961
+4,164
| +9% | +$17K |
|
2603
Lightwave Logic
LWLG
$417M
| $204K | ﹤0.01% |
198,237
+32,469
| +20% | +$33.4K |
|
2604
MarineMax
HZO
$556M
| $203K | ﹤0.01% |
9,424
+710
| +8% | +$15.3K |
|
2605
P10
PX
$1.33B
| $203K | ﹤0.01% |
17,239
+1,482
| +9% | +$17.5K |
|
2606
SelectQuote
SLQT
$361M
| $203K | ﹤0.01% |
60,598
+8,779
| +17% | +$29.4K |
|
2607
Trevi Therapeutics
TRVI
$1B
| $203K | ﹤0.01% |
32,162
+6,996
| +28% | +$44.2K |
|
2608
DocGo
DCGO
$150M
| $203K | ﹤0.01% |
76,617
+745
| +1% | +$1.97K |
|
2609
FTAI Infrastructure
FIP
$518M
| $203K | ﹤0.01% |
44,731
+5,733
| +15% | +$26K |
|
|
FSP
2610
Franklin Street Properties
FSP
$174M
| $203K | ﹤0.01% |
113,639
+2,071
| +2% | +$3.7K |
|
2611
Fulcrum Therapeutics
FULC
$379M
| $203K | ﹤0.01% |
70,168
+17,800
| +34% | +$51.5K |
|
2612
Aldeyra Therapeutics
ALDX
$324M
| $202K | ﹤0.01% |
35,083
+2,978
| +9% | +$17.1K |
|
2613
Citizens
CIA
$274M
| $202K | ﹤0.01% |
44,300
+9,400
| +27% | +$42.9K |
|
2614
Oil-Dri
ODC
$959M
| $202K | ﹤0.01% |
+4,382
| New | +$202K |
|
2615
Mission Produce
AVO
$900M
| $201K | ﹤0.01% |
19,110
+1,718
| +10% | +$18.1K |
|
2616
RPC Inc
RES
$986M
| $201K | ﹤0.01% |
36,496
+4,482
| +14% | +$24.7K |
|
2617
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $200K | ﹤0.01% |
+4,549
| New | +$200K |
|
2618
KVH Industries
KVHI
$119M
| $200K | ﹤0.01% |
37,763
| – | – |
|
2619
ImmunityBio
IBRX
$2.46B
| $199K | ﹤0.01% |
66,101
+9,813
| +17% | +$29.5K |
|
2620
Inogen
INGN
$231M
| $199K | ﹤0.01% |
27,800
+1,090
| +4% | +$7.8K |
|
2621
Cipher Mining
CIFR
$4.27B
| $198K | ﹤0.01% |
86,009
+7,417
| +9% | +$17.1K |
|
2622
Mineralys Therapeutics
MLYS
$2.88B
| $198K | ﹤0.01% |
12,417
+702
| +6% | +$11.2K |
|
2623
Ardagh Metal Packaging
AMBP
$2.13B
| $197K | ﹤0.01% |
64,930
+7,342
| +13% | +$22.3K |
|
2624
Grindr
GRND
$3.09B
| $197K | ﹤0.01% |
+10,986
| New | +$197K |
|
2625
Marcus Corp
MCS
$504M
| $197K | ﹤0.01% |
11,781
+909
| +8% | +$15.2K |
|